CVS Health Corp. buy BiotechBee
Summary
This prediction ended on 05.05.23 with a price of €62.58. Massive losses of -36.93% were the result for the BUY prediction by BiotechBee. Dividends of €1.67 are taken into consideration when calculating the performance. BiotechBee has 80% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
CVS Health Corp. | -1.020% | -1.020% | -16.618% |
iShares Core DAX® | 2.147% | 2.681% | 17.410% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% |
According to BiotechBee what are the pros and cons of CVS Health Corp. for the foreseeable future?
Pros
Cons
Comments by BiotechBee for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.